Placental Stem Cell Therapy Market to Surpass US$ 4.4 Bn by 2030, Underpinned by Enormous R&D in Cellular Therapies and Regenerative Medicine, Finds…

Growing application of mesenchymal stromal cells (MSCs) as cellular therapeutic agents in various neurological and immune disorders to generate massive revenues in placental stem cell therapy market

Players lean on augmenting production of human amniotic epithelial cells (hAECs) for treating congenital metabolic diseases; Asia Pacific to present sizable revenue streams

ALBANY, N.Y., Jan. 3, 2022 /PRNewswire/ -- Transparency Market Research: Companies in the placental stem cell therapy market have been recently exploring the therapeutic potential of mesenchymal stromal/stem cells (MSCs) for treating severe COVID-19. Particularly in acute respiratory distress syndrome (ARDS), MSCs have demonstrated high efficacy and safety, due to their immunomodulation and differentiation properties. The revenue in the global market is estimated to surpass US$ 4.4 Bn by 2030.H

TMR_Logo_Logo

A growing number of preclinical and clinical studies are exploring new therapeutic approaches utilizing placental MSCs for lung diseases, idiopathic pulmonary fibrosis (IPF), and cystic fibrosis (CF). This has extended the sales revenue potential, assert analysts in a TMR study on the placental stem cell therapy market.

Asia Pacific held a leading share of the global placental stem cell therapy market in 2019. Enormous R&D in regenerative therapies in the region has spurred lucrative opportunities for players in recent years.

Request Brochure of Placental Stem Cell Therapy Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81612

Evaluation of safety and effectiveness of transplantation of human amniotic epithelial cells (hAECs) in various inflammatory and immune-based diseases. These have generated groundswell of attention, notably due to their ease of isolation, abundance, and non-immunogenic and non-tumorigenic properties. Moreover, ongoing clinical studies in hAECs are expected to pave way to innovative regenerative medicines for wound healing.

Story continues

Key Findings of Placental Stem Cell Therapy Market Study

Robust Analytics and Independent Measurement Systems to Enrich Market Landscape: Players are keenly adopting technologies and techniques to ensure consistent quality of stem cells in order to expand the clinical applications of placental stem cell therapies. Extensive research on the characterization of placental stem cell therapies pivots on strides in biobanking technologies.

Request for Analysis of COVID-19 Impact on Placental Stem Cell Therapy Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=81612

Such advances have supported substantial R&D funding on cell transplantation therapy in retinitis pigmentosa, thereby opening a new frontier, concurs the TMR study on the placental stem cell therapy market. In particular, transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) is attracting special attention.

Rising Number of Allogeneic Stem Cell Transplantations Holds Promise for Regenerative Medicine: Growing utility of human amniotic/amnion epithelial cells (hAECs) in regenerative medicine has catalyzed significant investments in the placental stem cell therapy market over the past few years. Allogeneic hAECs are showing potential for leukemia and bronchopulmonary dysplasia (BPD) in various phases of clinical trials. The growing number of allogeneic stem cell transplantation procedures in developed nations has enriched the sales prospects in the placental stem cell therapy market.

MSC-based Cell Therapies Expand Prospects: Continued advances in cell-based therapies have engendered industry efforts in utilizing placental stem cell therapy for various diseases, expanding the sales prospects of the placental stem cell therapy market. These mainly include lung and liver injury, neurological disorders, acute kidney failure, and cardiovascular diseases. Especially in case of neurological disorders, mesenchymal stem/stromal cells (MSCs)-based cell therapy products are showing good therapeutic efficacy. For instance, allogeneic stem cell transplants have shown effectiveness in Alzheimer's disease in animal studies.

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=81612

Placental Stem Cell Therapy Market: Key Drivers

Growing need for precision cell-based therapies has led to a spurt in R&D in placental stem cell products both in in-vitro and in vivo, thus unlocking lucrative avenues

Rising social and economic burden of age-related neurological disorders has generated massive attention of stem cell companies globally. Researchers are increasingly exploring these therapies to develop novel treatments for Parkinson's disease, stroke, traumatic brain injury, and Huntington's disease.

Buy Placental Stem Cell Therapy Market Report https://www.transparencymarketresearch.com/checkout.php?rep_id=81612&ltype=S

Placental Stem Cell Therapy Market: Key Players

Some of the key players in the placental stem cell therapy market are

Global Placental Stem Cell Therapy Market: Segmentation

Placental Stem Cell Therapy Market, by Application

Placental Stem Cell Therapy Market, by End User

Hospitals & Specialty Clinics

Clinical Research Organizations

Research Institutes & Academies

Placental Stem Cell Therapy Market, by Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Surgical Kits Market: The surgical kits market is projected to reach the valuation of US$ 40 Bn by 2031. Companies are unlocking growth opportunities in dentistry to introduce digital revolution. For instance, DIO Implant - an implant services provider is gaining recognition for its DIOnavi surgical kit, which supports the basics of digital implant dentistry.

Downstream Processing Market: The latest advancements in downstream processing include ligand technologies for purifying RNA and COVID-19 vaccines. Companies in the downstream processing market are in many talks such as Navigo Proteins and Repligan, who have developed an affinity ligand targeting the SARS-CoV-2 spike protein for the purification of COVID-19 vaccines.

Central Lab Market: The central lab market is estimated to surpass US$ 4.1 Bn mark by 2030. However, central lab stakeholders are posed with many challenges, such as time consuming processes, since several sites samples need to reach one lab and may take several days.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

ContactMr. Rohit BhiseyTransparency Market ResearchState Tower,90 State Street, Suite 700,Albany NY 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comFollow Us: Twitter | LinkedInBlog: https://tmrblog.comBrowse PR - https://www.transparencymarketresearch.com/pressrelease/placental-stem-cell-therapy-market.htm

Cision

View original content:https://www.prnewswire.com/news-releases/placental-stem-cell-therapy-market-to-surpass-us-4-4-bn-by-2030--underpinned-by-enormous-rd-in-cellular-therapies-and-regenerative-medicine-finds-tmr-study-301452183.html

SOURCE Transparency Market Research

Here is the original post:

Placental Stem Cell Therapy Market to Surpass US$ 4.4 Bn by 2030, Underpinned by Enormous R&D in Cellular Therapies and Regenerative Medicine, Finds...